Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NPY5R antagonists(Neuropeptide Y receptor type 5 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H26F2N4O2 |
InChIKeyYMZIGLKNGLXQDX-UHFFFAOYSA-N |
CAS Registry405054-98-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | US | 28 Dec 2008 |